Red_Block.jpgEvestra_Logo_with_caption.jpgClean_EvestraLogo_2012.jpgClean_EvestraLogo_2012.jpg Maika_and_girl.jpgMonika_cycling.jpgBindu_reaching.jpg


Hormonal Dependent Breast Cancer

The biggest risk factor of developing breast cancer is being a woman. It is much more common in women than in men. According to the Breast Cancer Society, there will be about 190,000 new cases of invasive breast cancer and 60,000 cases of non-invasive breast cancer this year in American women. Other risk factors are age, family history and genetics. But there are behaviors that can lead to the development of breast cancer, such as smoking, being overweight, lack of exercise or drinking alcohol. Some of them are interrelated but, by choosing a healthy lifestyle, the risk can be minimized.

Breast cancer knows no boundaries of race, age or class.

Breast cancer is the second most common type of cancer Worldwide.

Breast cancer is the fifth most common cause of cancer death.

Hormonal Breast Cancer Therapies


October is declared as national breast cancer awareness month. The pink ribbon is an international symbol of breast cancer awareness.

The best breast cancer treatments are multidisciplinary and involve surgeons, medical oncologists, and radiation oncologists. Hormone dependent breast cancer can be treated with hormone therapy medicine. Aromatase inhibitors work by inhibiting the action of the enzyme aromatase, which converts androgens into estrogens by a process called aromatization. As breast tissue is stimulated by estrogens, decreasing the production is a way of suppressing recurrence of the breast tumor tissue.

Adapting and modifying emerging oncology treatments represents the future of cancer-fighting therapies. This includes earlier detection and increasingly sophisticated means of administering more targeted treatments.



© 2017 Evestra, Inc.